|
SFDA solicits opinions on Inspection Standard for Good Manufacturing Practice for Pharmaceutical Products (draft for comments)
|
|
To implement Drug Administration Law of the People's Republic of China and Regulations for Implementation of the Drug Administration Law of the People's Republic of China, further improve GMP inspection, the Department of Drug Safety and Inspection of the State Food and Drug Administration revised the Inspection Standard for Good Manufacturing Practice for Pharmaceutical Products (Interim). It now solicits opinions from provincial-level drug regulatory departments and requires giving feedbacks before September 30, 2006.
| |
|
|
